All Stories

  1. Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method
  2. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
  3. Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
  4. Contact Urticaria and Related Conditions: Clinical Review
  5. WAO - ARIA consensus on chronic cough: Executive summary
  6. Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
  7. Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
  8. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  9. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
  10. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
  11. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
  12. Etiology of bronchiectasis in Qatar: A retrospective study
  13. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
  14. The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up
  15. Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
  16. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
  17. Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
  18. Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
  19. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
  20. Uncovering a neurological protein signature for severe COVID-19
  21. A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
  22. Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
  23. Case report: Challenges in the diagnosis of Eosinophilic esophagitis
  24. Circulating microRNA signatures in patients with chronic Urticaria
  25. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
  26. The Second Qatar Allergy and Immunology Conference: An Editorial
  27. The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
  28. Predictors of Early Death Among Untransplanted Patients with Combined immunodeficiencies affecting cellular and humoral immunity
  29. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity
  30. Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report
  31. Anaphylaxis after prick‐to‐prick skin test to seafood allergy: A rare adverse event
  32. BCG Vaccine–associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
  33. Aerobiological monitoring in a desert type ecosystem: Two sampling stations of two cities (2017–2020) in Qatar
  34. Digital tools in allergy and respiratory care
  35. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
  36. Contributions of nurse specialists in the allergy and immunology service and patient care
  37. Do we need aerobiological air monitoring in desert climates? The Qatar experience
  38. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
  39. Severity and outcome of COVID-19 disease in patients with allergic rhinitis during the pandemic in Qatar – A preliminary report
  40. Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
  41. Aspirin challenge and desensitization in patients with suspected AERD in Qatar
  42. Circulatory EVs as a predictor of chronic urticarial activity
  43. First allergy conference in Qatar: Let's explore allergy with a new lens
  44. Real-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
  45. SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
  46. Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
  47. First volumetric records of airborne Cladosporium and Alternaria spores in the atmosphere of Al Khor (northern Qatar): a preliminary survey
  48. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
  49. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study
  50. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  51. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  52. The correlation between middle schoolchildren allergic symptoms and airborne particle season
  53. Viral exanthem following influenza vaccine
  54. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar
  55. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
  56. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System
  57. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
  58. Association of endometriosis with interstitial cystitis in chronic pelvic pain syndrome: Short narrative on prevalence, diagnostic limitations, and clinical implications
  59. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  60. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  61. Abstract 13039: Putative Protective Effects Of Caffeine And Its Metabolites On Coronary Heart Disease In The Middle East
  62. Abstract 13041: Differences In Systemic Fatty Acids Between Coronary Heart Disease Patients And Controls From The Middle East Favors Inflammation
  63. Primary immunodeficiency and the microbiome
  64. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
  65. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
  66. METABOLOMICS REVEALS PERTURBATIONS IN ARGININE-NO METABOLISM, PURINE BIOSYNTHESIS AND CELLULAR ENERGY CHARGE IN PATIENTS WITH CORONARY HEART DISEASE
  67. REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION
  68. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
  69. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
  70. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
  71. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
  72. A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families
  73. The association between airborne pollen monitoring and sensitization in the hot desert climate
  74. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  75. Immunogenetics of Celiac Disease: A Focus on Arab Countries
  76. The Association Between Airborne Pollen Monitoring and Sensitization in the Hot Desert Climate
  77. Etiology and outcome of hemoptysis in Qatar, a high-resource country with a large expatriate population: A retrospective study
  78. A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
  79. Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study
  80. Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery
  81. Complex Regional Pain Syndrome Type I Following Tetanus Toxoid Injection
  82. Two cases of food-dependent exercise-induced anaphylaxis with different culprit foods
  83. Renal allograft tuberculosis with infected lymphocele transmitted from the donor
  84. Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
  85. Two Cases of Recurrent Episodes of Angio Edema Without Urticaria or Pruritus
  86. Prevalence of Pharmacogenetic Risk Alleles in a Consanguineous Middle Eastern Population.